Treace Medical Concepts Inc Total Assets
Treace Medical Concepts Inc total assets. Based on the latest financial reports, Treace Medical Concepts Inc (TMCI) holds total assets worth $184.10 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Treace Medical Concepts Inc (TMCI) market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of Treace Medical Concepts Inc (2019–2025)
Total assets of Treace Medical Concepts Inc from 2019 to 2025. This chart illustrates how Treace Medical Concepts Inc's total assets have evolved over time, based on quarterly financial data. See current stock price of Treace Medical Concepts Inc for real-time trading data and today's change.
Treace Medical Concepts Inc - Asset Composition Analysis
Treace Medical Concepts Inc Total Assets Breakdown (December 2025)
Treace Medical Concepts Inc total assets breakdown as of December 2025. Treace Medical Concepts Inc's total assets of $184.10 Million consist of 69.3% current assets and 30.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 5.6% |
| Accounts Receivable | $42.16 Million | 22.1% |
| Inventory | $36.03 Million | 18.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $7.12 Million | 3.7% |
| Goodwill | $12.81 Million | 6.7% |
Asset Composition Trend (2019–2025)
This chart illustrates how Treace Medical Concepts Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Treace Medical Concepts Inc working capital to net assets to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Treace Medical Concepts Inc's current assets represent 69.3% of total assets in 2025, a decrease from 96.1% in 2019.
- Cash Position: Cash and equivalents constituted 5.6% of total assets in 2025, down from 40.9% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, an increase from 0.0% in 2019.
- Asset Diversification: The largest asset category is accounts receivable at 22.1% of total assets.
Treace Medical Concepts Inc Competitors by Total Assets
Key competitors of Treace Medical Concepts Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
BMC Medical Co. Ltd. A
SHE:301367
|
China | CN¥3.59 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Hironic Co. Ltd
KQ:149980
|
Korea | ₩80.01 Billion |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
Treace Medical Concepts Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.58 | 4.50 | 14.28 |
| Quick Ratio | 2.53 | 3.36 | 13.50 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $88.98 Million | $116.26 Million | $130.96 Million |
Treace Medical Concepts Inc - Advanced Valuation Insights
This section examines the relationship between Treace Medical Concepts Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.10 |
| Latest Market Cap to Assets Ratio | 1.19 |
| Asset Growth Rate (YoY) | -12.2% |
| Total Assets | $190.58 Million |
| Market Capitalization | $227.70 Million USD |
Valuation Analysis
Above Book Valuation: The market values Treace Medical Concepts Inc's assets above their book value (1.19x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: Treace Medical Concepts Inc's assets decreased by 12.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Treace Medical Concepts Inc (2019–2025)
The table below shows the annual total assets of Treace Medical Concepts Inc from 2019 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $190.58 Million | -12.21% |
| 2024-12-31 | $217.09 Million | -13.82% |
| 2023-12-31 | $251.91 Million | +58.41% |
| 2022-12-31 | $159.02 Million | +12.93% |
| 2021-12-31 | $140.82 Million | +236.84% |
| 2020-12-31 | $41.81 Million | +40.69% |
| 2019-12-31 | $29.72 Million | -- |
About Treace Medical Concepts Inc
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D M… Read more